
Letrovian 5mg Tablet
Marketer
Vivichem Pharma
Salt Composition
Letrozole (5mg)
Overview Letrovian 5mg Tablet
Post-menopausal women with breast cancer may find relief with Letrovian 5mg tablets. This medication can be a standalone treatment or used in conjunction with other therapies like surgery or radiotherapy. In advanced breast cancer, it helps impede metastasis. Letrovian 5mg tablets may be ingested with or without food, always following the physician's prescribed dosage and duration for optimal results. Dosage frequency varies depending on the treatment goal; your doctor will personalize your regimen. Continue taking the medication as directed. Common side effects include sweating, tiredness, hot flashes, and elevated cholesterol. Report any concerning or persistent side effects to your doctor, who can offer mitigating strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or history of osteoporosis. Comprehensive disclosure of all other medications is crucial, as interactions may affect Letrovian's efficacy. Pregnant or breastfeeding women must consult their doctor before starting this treatment. Your doctor might order blood tests to monitor vitamin D levels and bone density throughout the treatment period.
Uses of Letrovian 5mg Tablet
Managing Breast Cancer
Major Benefits of Letrovian 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 5mg Letrovian tablet should be swallowed whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Letrovian 5mg Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Letrovian 5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letrovian 5mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Letrovian 5mg Tablet works:
Estrogen production is reduced by Letrovian 5mg tablets, which function as an aromatase inhibitor. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent ingestion of alcohol and Letrovian 5mg Tablet.
PregnancyUNSAFE
Use of Letrovian 5mg tablets is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in animal and human studies indicates substantial risks to fetal development.
Breast feedingUNSAFE
Lactation and Letrovian 5mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking a 5mg Letrovian tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Letrovian 5mg tablets are considered safe, and no dosage modifications are typically advised. Nevertheless, data regarding its use in patients with end-stage renal disease is scarce. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Letrovian 5mg tablets. Dosage modification of Letrovian 5mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Letrovian 5mg Tablet :
Should you forget a Letrovian 5mg Tablet dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Letrovian 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
